ABS Hospitals in 9 Inactive n/a n/a n/a n/a n/a n/a – European 137, 138 member 2008) states antibiotic strategies for appropriate use of antibiotics in hospitals in member states of the European 28 Current AMR Commercially Organism Hospital In vitro Aerobic and n/a participating surveillance funded by susceptibility facultative countries in Sharp & tests and Gram-negative publications 5 regions Dohme Corp. longitudinal bacilli (Asia-Pacific, (subsidiary of susceptibility Latin Merck & patterns of America, Co. Inc.) Gram-negative Middle bacilli isolated North from America and Europe) infections
ABS 137, 138 antibiotic strategies for appropriate use of antibiotics in hospitals in member states of the European Hospitals in 9 European member states Inactive n/a – n/a n/a n/a n/a n/a 28 participating countries in 5 regions (Asia-Pacific, Latin America, Middle North America and Europe) Current AMR surveillance Commercially funded by Sharp & Dohme Corp. (subsidiary of Merck & Co. Inc.) Organism Hospital In vitro susceptibility tests and longitudinal susceptibility patterns of Gram-negative bacilli isolated from infections Aerobic and facultative Gram-negative bacilli n/a publications 2008)
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx